TPG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TPG is not a strong buy right now for a beginner with a long-term horizon, even with $50,000-$100,000 to deploy. The stock is trading near short-term resistance, technicals are still bearish, and the options market is heavily skewed bearish. While analyst sentiment is mixed-to-positive and Q1 revenue growth was solid, the current setup does not justify an aggressive buy today for an impatient investor. I would not buy now; I would hold and wait for a clearer entry.
TPG is showing a mixed-to-bearish technical picture. The MACD histogram is negative at -0.0705, though it is contracting, which suggests downside momentum is easing. RSI_6 at 61.23 is neutral-to-mildly positive, not oversold. The moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, indicating the longer-term trend is still not fully supportive. Price at 42.67 is close to resistance at R1 42.947 and below R2 43.917, with pivot support at 41.377. The nearby upside is limited unless it breaks resistance decisively.
["Q1 revenue rose 20.7% year over year to $570 million, showing solid top-line growth.", "Several analysts maintained Buy/Overweight ratings and some raised price targets, including Goldman Sachs, UBS, and Barclays.", "The company monetized $9B in investments, supporting transaction and capital markets fees.", "TD Cowen noted long-term earnings power continues to climb."]
["TD Cowen lowered its price target to $45 and kept Hold, reflecting caution on current earnings quality.", "Morgan Stanley cut its price target to $60 from $67 and was only Equal Weight.", "Technical trend remains bearish with SMA_200 > SMA_20 > SMA_5 and negative MACD.", "Options data is strongly bearish, with put-call ratios heavily favoring puts.", "Similar-pattern stock analysis suggests downside risk over the next day, week, and month.", "Hedge fund and insider trading trends are neutral, providing no supportive buying signal."]
Latest quarter: Q1. TPG reported $570 million in revenue, up 20.7% year over year, which is a healthy growth rate. The available news also points to strong monetization activity and reaffirmed fiscal 2026 fundraising and margin guidance. However, the broader analyst commentary suggests earnings quality is still viewed as less robust, so the fundamental picture is improving but not yet compelling enough to offset the weaker trading setup.
Analyst sentiment is mixed but slightly constructive overall. Recent target moves include Goldman Sachs raising to $61 and keeping Buy, UBS raising to $59 and keeping Buy, Barclays raising to $58 and keeping Overweight, and BofA raising to $58 and keeping Buy. Offsetting that, TD Cowen lowered its target to $45 and kept Hold, Deutsche Bank cut to $55 while keeping Buy, and Morgan Stanley reduced its target to $60 and kept Equal Weight. Wall Street sees decent long-term earnings power and solid monetization, but also concerns about current earnings quality and a challenging backdrop. Net: mildly bullish fundamental view, but not a clean consensus buy.
